Evidence map›Paper›PMID 31468170›Full record

ReviewZeitschrift fur Rheumatologie2019

[Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany].

K Benesova, H-M Lorenz, V Lion, A Voigt, A Krause, O Sander, M Schneider, M Feuchtenberger, A Nigg, J Leipe and 16 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Frontiers in medicine · 2022
    Article
  14. Article
  15. [Digital diagnostic support in rheumatology].Zeitschrift fur Rheumatologie · 2021
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

K BenesovaSektion Rheumatologie, Innere Medizin V, Universitätsklinik Heidelberg, Heidelberg, Deutschland. karolina.benesova@med.uni-heidelberg.de.
H-M LorenzSektion Rheumatologie, Innere Medizin V, Universitätsklinik Heidelberg, Heidelberg, Deutschland.
V LionSektion Rheumatologie, Innere Medizin V, Universitätsklinik Heidelberg, Heidelberg, Deutschland.
A VoigtAbteilung Rheumatologie, klinische Immunologie und Osteologie, Standort Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Deutschland.
A KrauseAbteilung Rheumatologie, klinische Immunologie und Osteologie, Standort Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Deutschland.
O SanderPoliklinik und Funktionsbereich für Rheumatologie & Hiller Forschungszentrum Rheumatologie, UKD Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.
M SchneiderPoliklinik und Funktionsbereich für Rheumatologie & Hiller Forschungszentrum Rheumatologie, UKD Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.
M FeuchtenbergerMVZ MED|BAYERN OST Altötting·Burghausen, Burghausen, Deutschland.
A NiggMVZ MED|BAYERN OST Altötting·Burghausen, Burghausen, Deutschland.
J LeipeSektion Rheumatologie, V. Medizinische Klinik, Universitätsklinik Mannheim, Mannheim, Deutschland.
S BriemInnere Medizin und Rheumatologie, Alb-Donau Klinikum Langenau, Langenau, Deutschland.
E TiessenInnere Medizin und Rheumatologie, Alb-Donau Klinikum Langenau, Langenau, Deutschland.
F HaasRheumatologische Facharztpraxis, Tübingen, Deutschland.
M RihlRheumatologische Schwerpunktpraxis, Traunstein, Deutschland.
D Meyer-Olsonm&i Fachklinik Bad Pyrmont und MVZ Weserbergland, Bad Pyrmont, Deutschland.
X BaraliakosRheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Bochum, Deutschland.
J BraunRheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Bochum, Deutschland.
A SchwartingSchwerpunkt Rheumatologie und klinische Immunologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Deutschland.
M DreherSchwerpunkt Rheumatologie und klinische Immunologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Deutschland.
T WitteKlinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
G AssmannRheumatologie, Universitätsklinikum des Saarlandes, Homburg, Deutschland.
K HoeperRegionales Kooperatives Rheumazentrum Niedersachsen e. V., Hannover, Deutschland.
R E SchmidtKlinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
P Bartz-BazzanellaKlinik für Internistische Rheumatologie, Rhein-Maas Klinikum, Würselen, Deutschland.
M GaubitzInterdisziplinäre Diagnostik und Therapie - Akademie für Manuelle Medizin, WWU Münster, Münster, Deutschland.
C SpeckerKlinik für Rheumatologie und Klinische Immunologie, Evang. Krankenhaus Essen-Werden, Kliniken Essen-Mitte, Essen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to reduce the prognostically relevant time interval between the initial manifestation of a rheumatic and musculoskeletal disease and diagnosis as well as the consecutive initiation of an appropriate treatment, several rheumatological centers in Germany have improved the access to initial rheumatologic evaluation by establishing early recognition/screening clinics at their respective sites. Corresponding models located at Altoetting·Burghausen, Bad Pyrmont, Berlin Buch, Duesseldorf, Heidelberg, Herne, Mannheim as well as supraregional/multicenter initiatives Rheuma Rapid, RhePort and Rheuma-VOR are presented in this overview along with the respective characteristics, potential advantages and disadvantages, but also first evaluation results of several models. The aim of this publication is to promote early detection of rheumatic and musculoskeletal diseases as one of the most important challenges in current rheumatology by encouraging further rheumatologic centers and practices to launch their own early recognition/screening consultation model on the basis of aspects presented herein.

Indexed as

Musculoskeletal DiseasesRheumatic DiseasesRheumatologyEarly DiagnosisGermanyHumansReferral and ConsultationAccess routesCapacity constraintConsultation modelsEarly treatmentInitial rheumatologic assessment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.